Sokoll K[au] - Search Results

Year	Number of Results
2000	1
2001	1
2004	4
2005	1
2006	3
2007	2
2008	2
2009	1
2012	1
2017	1
2018	1
2022	0

1

Pharmacological management of transient synovitis.

Sokoll KB, Helliwell P. Sokoll KB, et al. Expert Opin Pharmacother. 2006 Jan;7(1):35-46. doi: 10.1517/14656566.7.1.35. Expert Opin Pharmacother. 2006. PMID: 16370920 Review.

2

Nanoparticle Formulation Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel for Chemotherapy Delivery to the Brain.

Bteich J, Ernsting MJ, Mohammed M, Kiyota T, McKee TD, Trikha M, Lowman HB, Sokoll KK. Bteich J, et al. Among authors: sokoll kk. Bioconjug Chem. 2018 Jun 20;29(6):2009-2020. doi: 10.1021/acs.bioconjchem.8b00220. Epub 2018 May 23. Bioconjug Chem. 2018. PMID: 29734804

3

Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data.

Ames PR, Margarita A, Sokoll KB, Weston M, Brancaccio V. Ames PR, et al. Among authors: sokoll kb. Ann Rheum Dis. 2005 Feb;64(2):315-7. doi: 10.1136/ard.2004.023952. Epub 2004 May 21. Ann Rheum Dis. 2005. PMID: 15155372 Free PMC article.

4

Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease.

Wang CY, Finstad CL, Walfield AM, Sia C, Sokoll KK, Chang TY, Fang XD, Hung CH, Hutter-Paier B, Windisch M. Wang CY, et al. Among authors: sokoll kk. Vaccine. 2007 Apr 20;25(16):3041-52. doi: 10.1016/j.vaccine.2007.01.031. Epub 2007 Jan 19. Vaccine. 2007. PMID: 17287052

5

Using Flash Nanoprecipitation To Produce Highly Potent and Stable Cellax Nanoparticles from Amphiphilic Polymers Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel.

Bteich J, McManus SA, Ernsting MJ, Mohammed MZ, Prud'homme RK, Sokoll KK. Bteich J, et al. Among authors: sokoll kk. Mol Pharm. 2017 Nov 6;14(11):3998-4007. doi: 10.1021/acs.molpharmaceut.7b00670. Epub 2017 Oct 5. Mol Pharm. 2017. PMID: 28945432

6

BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000.

Yee CS, Isenberg DA, Prabu A, Sokoll K, Teh LS, Rahman A, Bruce IN, Griffiths B, Akil M, McHugh N, D'Cruz D, Khamashta MA, Maddison P, Zoma A, Gordon C. Yee CS, et al. Among authors: sokoll k. Ann Rheum Dis. 2008 Jun;67(6):873-6. doi: 10.1136/ard.2007.070847. Epub 2007 May 22. Ann Rheum Dis. 2008. PMID: 17519277 Free article.

7

Atherosclerosis in primary antiphospholipid syndrome.

Ames PR, Sokoll K, Weston M, Margarita A, Brancaccio V. Ames PR, et al. Among authors: sokoll k. Ann Rheum Dis. 2004 May;63(5):610-1; author reply 610-11. Ann Rheum Dis. 2004. PMID: 15082506 Free PMC article. No abstract available.

8

Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion.

Pandey NR, Renwick J, Misquith A, Sokoll K, Sparks DL. Pandey NR, et al. Among authors: sokoll k. Biochemistry. 2008 Feb 12;47(6):1579-87. doi: 10.1021/bi702148f. Epub 2008 Jan 12. Biochemistry. 2008. PMID: 18189424

9

Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: addressing treatment outside the current NICE guidance.

Chiu Y, Ostor AJ, Hammond A, Sokoll K, Anderson M, Buch M, Ehrenstein MR, Gordon P, Steer S, Bruce IN. Chiu Y, et al. Among authors: sokoll k. Clin Rheumatol. 2012 Jun;31(6):1005-12. doi: 10.1007/s10067-011-1936-6. Epub 2012 Jan 25. Clin Rheumatol. 2012. PMID: 22271229 Free PMC article.

10

A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis.

Taylor WJ, Marchesoni A, Arreghini M, Sokoll K, Helliwell PS. Taylor WJ, et al. Among authors: sokoll k. Semin Arthritis Rheum. 2004 Dec;34(3):575-84. doi: 10.1016/j.semarthrit.2004.05.001. Semin Arthritis Rheum. 2004. PMID: 15609261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results